2022 In Vitro Diagnostics (IVD) Market in Malaysia, Singapore and Indonesia: Featuring Caris Life Sciences, Cephei, CTK Biotech, Danaher and Dexcom Among Others

Key Facts

DUBLIN--(BUSINESS WIRE)--The "In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022" report has been added to ResearchAndMarkets.com's offering.
“In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022” > > Tweet this The Asia Pacific (APAC) region is a fast-growing in vitro diagnostics (IVD) market, which is witnessing increasing focus by leading global players in the market.
Southeast Asia has been identified as one of the key regions in APAC region offering significant opportunities for IVD companies.
Though the population is less than 6 million, the Singapore market is attractive for IVD companies and it has become a medical tourism hub in the region.